Review
Published on 25 Oct 2022
Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1042745
- 6,796 views
- 34 citations
22 articles related to "Antitumor Agent"
Articles
Original Research
Published on 14 Jul 2020
Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
in Epigenomics and Epigenetics
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2020.00454
- 5,557 views
- 17 citations
Review
Published on 25 Feb 2021
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.615930
- 13,819 views
- 28 citations
Original Research
Accepted on 16 Mar 2026
Evaluation of the Oncolytic Efficacy of Genetically Engineered Newcastle Disease Virus rNDV Against Hepatocellular Carcinoma Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
- 235 views
Review
Published on 23 Feb 2022
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.831612
- 4,992 views
- 6 citations
Original Research
Published on 25 Feb 2020
A Penicillin Derivative Exerts an Anti-Metastatic Activity in Melanoma Cells Through the Downregulation of Integrin αvβ3 and Wnt/β-Catenin Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00127
- 5,531 views
- 16 citations
Original Research
Published on 19 Jun 2023
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1192472
- 4,655 views
- 8 citations
Review
Published on 14 Aug 2023
Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1224151
- 10,293 views
- 18 citations
Original Research
Published on 15 Apr 2021
Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2021.621181
- 6,900 views
- 16 citations
Review
Published on 09 Mar 2026
The global regulator LaeA controls expression of genes involved in diverse primary and secondary metabolites biosynthesis and their secretion in fungi
in Microbiotechnology
Frontiers in Microbiology
doi 10.3389/fmicb.2026.1764309
- 627 views
Original Research
Published on 28 Nov 2019
Matrine Reverses the Warburg Effect and Suppresses Colon Cancer Cell Growth via Negatively Regulating HIF-1α
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01437
- 8,877 views
- 53 citations
Original Research
Published on 12 Dec 2024
Cross-disease transcriptomic analysis reveals DOK3 and PAPOLA as therapeutic targets for neuroinflammatory and tumorigenic processes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1504629
- 2,872 views
Original Research
Published on 18 Dec 2020
Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes
in Molecular Bacterial Pathogenesis
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2020.602958
- 4,950 views
- 12 citations
Original Research
Published on 06 Jul 2022
Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.938052
- 7,906 views
- 35 citations
Original Research
Published on 08 Jun 2021
miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.694491
- 3,979 views
- 13 citations
Original Research
Published on 05 Jun 2020
Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00808
- 4,334 views
- 11 citations